- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03630107
In-Use Test of a Cosmetic Product in Subjects With Chronically Itchy Scalp
In-Use Test of a Shampoo (WO 5101) in Subjects With Pruritus of the Scalp
The aim of the study is to evaluate the tolerance of the Shampoo (WO 5101) on the scalp by a dermatologist and by the subjects themselves after four weeks of regular product use.
Additional objective of this clinical in-use study was to evaluate the cosmetic features and the acceptance of the product by means of a questionnaire at the end of the 4-week treatment period.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hamburg, Germany, 20354
- SIT Skin Investigation and Technology Hamburg GmbH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age: ≥ 18 years
- with chronically itchy scalp
- normal to dry scalp or scalp prone to neurodermatitis
Exclusion Criteria:
- any deviation from the above-mentioned criteria
- users of sour hair conditioner
- subjects who wash their hair more than once a day
- other dermatological disorders (scars, moles) on the scalp
- known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
- topical medication in the test area within 1 month prior to study start
- systemic medication with anti-inflammatory agents and antibiotics within two weeks prior to starting of the study
- systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within four weeks prior to starting of the study
- severe internistic disease that leads to pruritus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: WO 5101 Shampoo for Scalp and Hair
WO 5101 is used in subjects with chronically itchy scalp
|
Wash the hair at least three times a week for a period of four weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dermatological Tolerance of the Test Product on the Scalp
Time Frame: baseline, four weeks
|
Change from Baseline at four weeks by the means of a dermatological assessment of scalp
all Parameters (a-j) were assessed by 6-tiered rating scale with 0.5 intervals (0=absent; 0.5=very slight, 1/1.5= slight; 2/2.5=moderate; 3/3.5=severe and 4=extreme) |
baseline, four weeks
|
|
Subjective Tolerance of the Test Product on the Scalp
Time Frame: baseline, four weeks
|
Change from baseline at four weeks by means of a self-assessment questionnaire (with 13 questions regarding cosmetic features of the product as well as satisfaction with cosmetic performance).
|
baseline, four weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cosmetic Features of the Test Product
Time Frame: baseline, four weeks
|
Change from Baseline for the Cosmetic Features (scalp feeling after application, fragrance, hair styling, combability, lightness of the hair) of the Test Product by the means of a questionnaire
|
baseline, four weeks
|
|
Reduction of Pruritus
Time Frame: baseline, four weeks
|
Change from Baseline Reduction of Pruritus at four weeks by the means of a questionnaire
|
baseline, four weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Kerstin Söhl, MD, Dermatologist
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LPS-05/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pruritus of the Scalp
-
Seoul National University Bundang HospitalCompletedDandruff | Seborrhoeic Dermatitis of the ScalpSouth Korea
-
University of ZurichUnknownPsoriasis Vulgaris | Psoriasis of ScalpSwitzerland
-
Dove Medical Press LtdThe Affiliated Hospital of Qingdao UniversityCompleted
-
University Hospital, LilleNational Research Agency, France; Clinical Investigation Centre for Innovative... and other collaboratorsCompletedObstetrical Complications | Monitoring Injury of Scalp of NewbornFrance
-
Cairo UniversityMohamed, Ahmed A., M.D.; Tarek Ahmed Radwan; Mohamed Mahmoud Mohamed; Hatem Abdellatif... and other collaboratorsCompletedAddition of Hyalase to Local Anesthetic in Scalp BlockEgypt
-
Moberg Pharma ABCompletedSeborrhoeic Dermatitis of the ScalpSweden
-
The Cleveland ClinicWithdrawnDiscoid Lupus Erthematosus of the ScalpUnited States
-
Hospital Universiti Sains MalaysiaCompletedEfficacy and Safety of MgSO4 as Adjuvant to Scalp BlockMalaysia
-
Moberg Pharma ABCompletedSeborrhoeic Eczema of the ScalpSweden
-
Post Graduate Institute of Medical Education and...RecruitingDiabetic Pruritus | Efficacy of Pregabalin in Controlling Diabetic Pruritus SeverityIndia
Clinical Trials on WO 5101 Shampoo for Scalp and Hair
-
Arbor Life LabsCompletedAndrogenetic Alopecia | Androgenic Alopecia | Hair Loss/Baldness | Hair Thinning | Telogen Effluvium | Thinning HairUnited States
-
Arbor Life LabsCompletedAndrogenetic Alopecia | Androgenic Alopecia | Hair Loss/Baldness | Hair Thinning | Telogen Effluvium | Thinning HairUnited States
-
NovoBliss Research Pvt LtdBlossom Microbiotics LLCActive, not recruiting
-
Lumenis Be Ltd.Recruiting
-
Erasmus Medical CenterCompleted
-
Lacer S.A.CompletedEvaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair LossAndrogenetic Alopecia (AGA) | Chronic Telogen EffluviumItaly
-
Lindsey BordoneWithdrawnAlopecia Areata | Alopecia Totalis | Alopecia Universalis
-
Centre Hospitalier Universitaire de Saint EtiennePierre Fabre Dermo CosmetiqueTerminatedSkin Cancer | Skin AgingFrance
-
Azienda Ospedaliera Universitaria Integrata VeronaSocieta Italiana dell'Ipertensione ArteriosaNot yet recruitingDyslipidemias | Treatment Adherence | Arterial Hypertension | Antihypertensive Drugs | StatinsItaly
-
Galderma R&DCompletedMale Pattern of Hair Loss, Androgenic AlopeciaUnited States